Deficiency of Type I Platelet-Activating Factor-Acetylhydrolase Catalytic Subunits Causes an Increase in Body Weight

Yasuhiro Nakamura1, Momoko Yoshida2, Kazunari Tanigawa1

  • 1Faculty of Pharma-sciences, Teikyo University.

Insights

Mice lacking type I platelet-activating factor-acetylhydrolase (PAF-AH) catalytic subunits showed increased body weight and food intake. This was associated with significantly decreased testosterone levels in knockout mice, suggesting a link between PAF-AH deficiency and male reproductive hormone levels.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Genetics

Background:

  • Type I platelet-activating factor-acetylhydrolase (PAF-AH) is a complex enzyme with unknown physiological functions.
  • Its catalytic subunits (α1 and/or α2) associate with a regulatory subunit (β).

Purpose of the Study:

  • To investigate the physiological role of type I PAF-AH catalytic subunits.
  • To determine the phenotype of knockout mice lacking these subunits compared to wild-type mice.

Main Methods:

  • Comparison of body weight and food intake between knockout and control mice.
  • Measurement of serum and testis testosterone levels using liquid chromatography-tandem mass spectrometry.

Main Results:

  • Knockout mice exhibited significantly increased body weight and food intake from 6 to 20 weeks of age.
  • A decrease in testis weight was observed in knockout mice.
  • Serum and testis testosterone levels were significantly reduced in knockout mice compared to controls.

Conclusions:

  • Deficiency in type I PAF-AH catalytic subunits leads to increased body weight in male mice.
  • Reduced testosterone levels contribute to the observed increase in body weight.
  • Type I PAF-AH plays a role in regulating body weight and testosterone levels in males.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
789
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
124